Preventing the Next Pandemic
New Zealand’s former prime minister Dame Jacinda Ardern joins the world’s leading infectious disease scientists and experts at BU to discuss how to prepare for future outbreaks.
After a Year in the White House, BU Infectious Diseases Expert Shares Lessons about Pandemic Response
Nahid Bhadelia has returned to BU after helping lead the Biden administration’s COVID-19 pandemic response and advising on preparing the world for future outbreaks.
Human Health Is Suffering Because of Climate Change
Public health experts at BU and Harvard are teaming up to diversify and expand the global network of climate and health researchers to reach better solutions.
BU Researchers Join $100 Million Effort to Fight Future Deadly Pathogens
Scientists from NEIDL and medical and dental schools part of Howard Hughes Medical Institute push to get ahead of pandemics like COVID-19.
NEIDL Researchers Discover New SARS-CoV-2 Weak Spot—Which Could Inspire Improved Vaccines
Nature publishes BU-led COVID study that made international headlines; scientists find viral protein called NSP6, not just spike, responsible for making Omicron less dangerous than past variants.
BU’s New Center on Forced Displacement Will Address the Global Refugee Crisis
The center hopes to bring in talent from across the University with research projects spanning the arts to medical technology.
Nancy J. Sullivan, Ebola Vaccine and Treatment Pioneer, Named New NEIDL Director
Says priorities will include global engagement, strong science, and diversity, equity, and inclusion.
BU’s Nahid Bhadelia Joins White House COVID-19 Response Team
Bhadelia, an infectious diseases physician and global leader in pandemic preparedness, named senior policy advisor for global COVID response.
Building a Diverse, Strong Climate Workforce
Climate leaders from Boston University and around the country briefed Congressional staff on how they are working to train the next generation for careers solving the climate crisis.
Can We Prevent Antibiotic Resistance?
Antibiotics are losing effectiveness—and millions are dying as a result. CARB-X, a BU-based partnership that aims to solve antimicrobial resistance, has been given up to $370 million in new funding from the US government and charitable foundation Wellcome.